Dr. Noah Davidsohn: A 10-Minute Gene Therapy That May Add Decades of Healthy Life
Dr. Noah Davidsohn of Rejuvenate Bio explains how a single 10-minute gene-therapy infusion could deliver a decade or more of benefit. He describes how FGF-21 protects the heart and metabolism, and how partial cellular reprogramming with OSK doubled the remaining lifespan of very old mice.
Overview
In this conversation with Modern Healthspan, Dr. Noah Davidsohn, chief scientific officer and co-founder of Rejuvenate Bio, catches us up on two tracks of his work: systemic gene therapy and in-vivo partial reprogramming. His lead animal-health candidate, built on an anti-TGF-beta-1 protein and FGF-21, has extended life in dogs with mitral valve disease by one to two years in a Tufts pilot study, with conditional approval targeted around 2028.
The same FGF-21 protein anchors a human program; FGF-21, the so-called starvation hormone, delivers metabolic and cardiac benefits similar to GLP-1 without needing to eat less. Davidsohn explains why he chose secreted proteins delivered to the liver with an adeno-associated virus, turning liver cells into a 'biofactory' that releases therapeutic proteins throughout the body. Because the AAV sits beside the DNA rather than integrating into it, a single infusion can last a decade or more.
He then walks through his 2024 study in which cycling OSK on and off in 124-week-old mice doubled their remaining lifespan and reversed a frailty index. He is candid about limits: delivery reaches only a fraction of cells, so 'the river pushes back' against full rejuvenation. He closes with timelines, cost reductions, and a WeFunder campaign that lets the public invest in the science. This is an educational wellness discussion, not medical advice.
Key quotes
5It is a 10-minute infusion into the vein, and then it is there semi-permanently for the dog's lifespan.
It's like a little biofactory in your body.
Everything's interconnected, and if you go after aging, everything gets better.
You're pushing upstream, but you can only push so much before the river pushes back.
If it only costs $2,000 and you're getting 10 to 20 years of extra healthy lifespan, society could fit the bill for something like that.
Key ideas
8The dog mitral valve disease program
An anti-TGF-beta-1 protein plus FGF-21 extended life in dogs with mitral valve disease by one to two years in a Tufts pilot, with conditional approval targeted around 2028.
A decade from a single injection
A single 10-minute infusion has shown up to 10 years of sustained therapeutic benefit in dogs, because the gene therapy stays active for most of the animal's life.
FGF-21, the 'starvation hormone'
FGF-21 rises when you eat less and carries many of GLP-1's benefits, improving metabolism, cholesterol and triglycerides without requiring reduced food intake.
A systemic 'biofactory' approach
Rather than target one organ, Davidsohn delivers secreted proteins to the liver so liver cells pump therapeutic proteins throughout the whole body.
Why the AAV doesn't integrate
The adeno-associated virus leaves DNA beside the genome as an episome, so it is not copied during cell division — a built-in safety feature.
Partial reprogramming with OSK
Using three of the four Yamanaka factors (OSK) cycled on and off made old mice biologically younger and healthier without turning cells into stem cells.
The 'river pushes back'
Because delivery reaches only a fraction of cells, old signals in the untreated cells keep pushing the body toward its aged state, limiting rejuvenation.
The Belmonte senescence comparison
A separate lab triggered OSK only in senescent cells and saw a similar 12–14% overall lifespan gain, echoing Davidsohn's results from a different experiment.
Practical takeaways
6- 1
Once-and-done solves adherence 6:00
A single infusion that lasts years removes the daily-pill adherence problem that undermines many therapies.
- 2
FGF-21 may complement GLP-1 thinking 9:30
FGF-21 offers metabolic and especially cardiac benefits and could expand across indications the way GLP-1s did — framed here as science, not a recommendation.
- 3
Pulsed dosing avoids full stemness 24:30
Turning the factors on and off in cycles, using an antibiotic as a switch, keeps cells from fully becoming stem cells.
- 4
Three factors instead of four is safer 28:00
Dropping the cancer-associated Myc factor and keeping expression temporary reduces the risk of cells becoming cancerous.
- 5
FGF-21 may support the immune system 41:00
FGF-21 appears to reverse thymic involution, potentially helping T cells be trained again as the thymus shrinks with age.
- 6
Clinic timelines are nearer than for full approval 47:40
Davidsohn estimates his reprogramming program is about two years from the clinic, with 'numerous somethings' in the field within five years.
Topics & chapters
14Teaser: doubling lifespan in old mice
Old mice given cycled OSK therapy lived twice as long and looked healthier, hinting at affordable decades of extra healthy life.
Welcome and the dog program
An update on the animal-health candidate for canine mitral valve disease, built on anti-TGF-beta-1 and FGF-21.
A single 10-minute infusion
The dog therapy is a one-time, 10-minute vein infusion that stays active for the animal's lifespan.
FGF-21: the human program
The human program uses liver-directed FGF-21, the 'starvation hormone,' for metabolic and cardiac benefit.
Approval timeline for FGF-21
One GMP batch and one primate study stand between the program and first-in-human trials.
How liver-directed therapy works
An AAV drops DNA into liver cells, which then secrete therapeutic proteins systemically like a biofactory.
Once-and-done and non-integrating AAV
Because the virus doesn't integrate into the genome, a single human dose may last a decade or more.
The 2024 OSK reprogramming study
Three Yamanaka factors cycled on and off partially reprogrammed cells in very old mice.
Pulsed dosing and three-factor safety
Antibiotic-controlled cycling and dropping Myc keep cells from becoming stem cells or cancerous.
Why it doesn't reset you to 25
Old signals and partial delivery mean the body resists wholesale rejuvenation — the river pushes back.
Better delivery and cause of death
Companies are improving viral targeting; the study lacked enough mice to pinpoint cause of death.
FGF-21 and the immune system
FGF-21 may reverse thymic involution and support immune function more than OSK does.
Epigenetic age and no stem cells
Epigenetic rejuvenation was most pronounced in the heart, with no stem cells or toxicity observed.
Road to the clinic and investing
Cost reductions, clinic timelines, and a WeFunder campaign that lets the public invest in Rejuvenate Bio.